Publications by authors named "YunLing Lin"

Claim this Profile
D
Development and validation of a novel prediction model for new-onset atrial fibrillation after lung resection.
Yasha Chen, Yangxi Hu, Jiamei Wang, Jianmin Sun, Bowen Hu, Yunling Lin

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based image segmentation model using an MRI-based convolutional neural network for physiological evaluation of the heart.
Wanni Xu, Jianshe Shi, Yunling Lin, Chao Liu, Weifang Xie

Front Physiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Aromatherapy at Relieving the Work-Related Stress of Nursing Staff from Various Hospital Departments during COVID-19.
Chi-Lun Hung, Yun-Ling Lin, Chin-Mei Chou, Ching-Ju Wang

Healthcare (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report.
Yunling Lin, Xun Yuan, Lianglong Chen

Front Cardiovasc Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Iodinated Contrast Media in Patients Received Percutaneous Coronary Intervention: Focus on Thyroid Disease.
Yasha Chen, Xueyang Zheng, Na Li, Wenhao Niu, Bowen Hu, Yunling Lin

Front Endocrinol (Lausanne)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction.
HuiYa Li, DanQing Hu, Guilin Chen, DeDong Zheng, ShuMei Li, YunLing Lin, LingZhen Wu

Cell Death Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes.
Jun Fang, ZhiXiong Wei, DeDong Zheng, Teng Ying, HuaShan Hong, YunLing Lin, LingZhen Wu

J Am Heart Assoc· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of high-mobility group box-1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate.
Yunling Lin, Lianglong Chen, Weiwei Li, Jun Fang

Exp Ther Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats.
Jun Fang, Lianglong Chen, Lin Fan, Liming Wu, Xiangqi Chen, Yunling Lin

J Mol Cell Cardiol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ameliorative effect of astaxanthin on endothelial dysfunction in streptozotocin-induced diabetes in male rats.
Zi-Wen Zhao, Wei Cai, Yun-Ling Lin, Qing-Fei Lin, Qiong Jiang, Zhang Lin

Arzneimittelforschung· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
Wei CAI, Jun FANG, Zhao-yang CHEN, Yun-ling LIN, Li-ming WU

Zhonghua Xin Xue Guan Bing Za Zhi· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction.
Lin Fan, Chaogui Lin, Shuangmu Zhuo, Lianglong Chen, Nan Liu, Yunling Lin

Eur J Heart Fail· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of standard versus low-dose tirofiban for percutaneous coronary intervention in very elderly patients with high-risk acute coronary syndrome.
Yun-ling Lin, Liang-long Chen, Yu-kun Luo, Xing-chun Zheng, Wei-wei Li

Acta Pharmacol Sin· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis